Title |
Cytochrome c: potential as a noninvasive biomarker of drug-induced acute kidney injury
|
---|---|
Published in |
Expert Opinion on Drug Metabolism & Toxicology, April 2012
|
DOI | 10.1517/17425255.2012.679657 |
Pubmed ID | |
Authors |
David M Small, Glenda C Gobe |
Abstract |
Acute kidney injury (AKI) in critically ill patients is closely associated with increased morbidity and mortality, yet there remains continued reliance on increased serum creatinine and blood urea nitrogen to diagnose AKI. These biomarkers increase only after significant renal structural damage has occurred. Recent research efforts have focused on discovery and validation of novel serum and urine biomarkers to detect AKI prior to extensive structural damage. Cytochrome c is best known as an indicator of cell death burden in any organ or tissue. It is released during mitochondrial damage that is associated with processing of apoptosis, cell lysis during necrosis and even reversible mitochondrial and cell injury. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 20 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 4 | 20% |
Researcher | 4 | 20% |
Student > Master | 4 | 20% |
Student > Bachelor | 3 | 15% |
Lecturer > Senior Lecturer | 1 | 5% |
Other | 1 | 5% |
Unknown | 3 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 6 | 30% |
Medicine and Dentistry | 5 | 25% |
Biochemistry, Genetics and Molecular Biology | 2 | 10% |
Veterinary Science and Veterinary Medicine | 1 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Other | 2 | 10% |
Unknown | 3 | 15% |